v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue $ 622,000 $ 626,000
Cost of revenue 373,000 629,000
Gross profit 249,000 (3,000)
Operating expenses:    
Research and development 3,000 50,000
Sales and marketing 8,000 54,000
General and administrative 929,000 1,077,000
Total operating expenses 940,000 1,181,000
Operating loss (691,000) (1,184,000)
Interest income, net (26,000) (48,000)
Loss before income taxes [1] (665,000) (1,136,000)
Income tax expense 7,000 0
Net loss (672,000) (1,136,000)
Preferred stock dividends 12,000 44,000
Net loss attributable to common stockholders $ (684,000) $ (1,180,000)
Net loss attributable to common stockholders per share:    
Basic and diluted net loss per share (in dollars per share) $ (0.59) $ (2.02)
Weighted-average number of shares of common stock:    
Basic and diluted (in shares) 1,151,482 584,603
[1] Other income (expense) for our segments includes interest expense and non-operating income. Corporate other income includes interest income on our cash and cash equivalents.